Medical Researchers Seek Federal Approval to Test Plant Compound for Brain Damage and Trauma

Scottsdale, Wednesday, 29 July 2026.
Scottsdale Research Institute submitted an FDA application for ibogaine hydrochloride, aiming to initiate 2027 clinical trials to restore neural function in veterans and civilians facing severe psychological trauma.